News Detail

We are seeking a dynamic and ambitious candidate to unraveling the molecular intricacies of genomic instability associated with metabolic alterations in p53-deficient tumour. By using both in vivo models and in vitro cellular systems, the project will employ high-throughput genomics techniques to decipher key metabolic-driven alterations in the epigenetic networks linked to genomic instability. The successful candidate will join the Doctoral Programme of the "Death Decision" Consortium, a DFG-funded collaborative initiative between the University of Konstanz, University of Fribourg, and Technical University of Munich. As a member of the consortium, the student will benefit from access to a world-class scientific environment, tailored qualification and training programs, and the opportunity to work on cutting-edge research.
For more information on the position and/or application procedure please email amelio.office@uni-konstanz.de